Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]iqvia"
Count: 127
Selected: 0
| NCT ID | Title |
|---|
| NCT04368065 | COVID-19 Active Research Experience (CARE) | ||
| NCT04025307 | Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours | ||
| NCT04907968 | Study of Upifitamab Rilsodotin in Combination With Other Agent(s) in Participants With High-grade Serous Ovarian Cancer | ||
| NCT04072835 | Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 | ||
| NCT05066698 | ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects | ||
| NCT03983980 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | ||
| NCT03956355 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001) | ||
| NCT04053387 | Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) | ||
| NCT03628235 | HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States | ||
| NCT04188574 | A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail | ||
| NCT04396340 | First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b | ||
| NCT04720378 | Safety and Tolerability Study of IV ST266 in COVID-19 Subjects | ||
| NCT02678572 | Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma | ||
| NCT05037760 | Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis | ||
| NCT04123574 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | ||
| NCT05030831 | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE | ||
| NCT04167137 | Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects | ||
| NCT03466320 | DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2 | ||
| NCT05084508 | A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age | ||
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT04535986 | A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD | ||
| NCT04333147 | Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) | ||
| NCT05633407 | Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS | ||
| NCT04600752 | Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India | ||
| NCT04542057 | A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD | ||
| NCT03583164 | Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options | ||
| NCT05632211 | A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants | ||
| NCT04877691 | Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus | ||
| NCT05551195 | [Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression] | ||
| NCT04718103 | A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT04125290 | US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI) | ||
| NCT05035680 | Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion | ||
| NCT04280029 | SELUTION SLR™ 014 In-stent Restenosis | ||
| NCT04484935 | Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children | ||
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ||
| NCT05599334 | A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib | ||
| NCT04612725 | A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO) | ||
| NCT05286853 | A Study of Renal Autologous Cell Therapy (REACT™) in Participants With Type 2 Diabetes and Chronic Kidney Disease | ||
| NCT04625972 | Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults | ||
| NCT04605094 | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis | ||
| NCT03980483 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate | ||
| NCT03970837 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) | ||
| NCT05560646 | A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain | ||
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT05055921 | MultiPulse Therapy (MPT) for AF (US) | ||
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | ||
| NCT05243680 | An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103) | ||
| NCT04818801 | Safety, Reactogenicity and Immunogenicity Study of ReCOV | ||
| NCT04027439 | Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler | ||
| NCT05546905 | A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) |
